Whole genome sequencing (30X)
Ended Purchase Order Awarded Last action
- Contract number
- HHSN261201800062P
- Awardee
-
Macrogen Clinical Laboratory, Inc. UEI Q2NPHRMVAQ19
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $22,485
Award facts
- Contract value 100% obligated
- $22,485.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Cancer Institute awarded a purchase order to Macrogen Clinical Laboratory, Inc. for whole genome sequencing (30X) on November 29, 2017, with a ceiling value of $22,485.00. Performance occurs in Bethesda, Maryland, with an ultimate completion date of January 31, 2018. The order is firm fixed price and carries no small business set-aside.
Quick answers
Who was awarded contract HHSN261201800062P?
HHSN261201800062P was awarded to Macrogen Clinical Laboratory, Inc. by National Cancer Institute (National Institutes of Health) on November 29, 2017.
How much is contract HHSN261201800062P worth?
The government has obligated $22,485 on HHSN261201800062P.
Was contract HHSN261201800062P competed?
The extent of competition for HHSN261201800062P was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award